NON CONTROLLING INTEREST (Details Narrative) - shares |
1 Months Ended | ||
|---|---|---|---|
Mar. 26, 2026 |
Oct. 31, 2020 |
Jul. 28, 2016 |
|
| BioCorRx Pharmaceuticals, Inc [Member] | |||
| Ownership percentage held by company | 75.80% | ||
| Ownership percentage held by former officers | 24.20% | ||
| BioCorRx Inc. [Member] | |||
| Common stock shares issued in exchange | 2,263,371 | ||
| Ownership interest | 12.15% | ||
| Joseph DeSanto MD [Member] | |||
| Descirption of management services agreement | a management fee equal to 65% of the Medical Corporation’s gross collected monthly revenue | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|